Literature DB >> 30139338

Opisthorchiasis with proinflammatory cytokines (IL-1β and TNF-α) polymorphisms influence risk of intrahepatic cholangiocarcinoma in Thailand: a nested case-control study.

Supannee Promthet1,2, Nopparat Songserm2,3, Somkiattiyos Woradet2,4, Chamsai Pientong5,6, Tipaya Ekalaksananan7,8, Surapon Wiangnon2, Akhtar Ali9.   

Abstract

BACKGROUND: Chronic inflammation and repeated infection with Opisthorchis viverrini (O. viverrini) induces intrahepatic cholangiocarcinoma (ICC). Inflammatory cytokines such as interleukin (IL) and tumor necrosis factor (TNF) are substances in the immune system that promote inflammation and causes disease to progress. Genes that help express proinflammatory cytokines can affect an individual's susceptibility to disease, especially in cancer-related chronic inflammation. This study aimed to investigate risk factors for ICC with a focus on opisthorchiasis and polymorphisms of proinflammatory cytokines (IL-1β and TNF-α).
METHODS: This study was a nested case-control study within a cohort study. 219 subjects who developed a primary ICC were identified and matched with two non-cancer controls from the same cohort based on sex and age at recruitment (±3 years). An O. viverrini-IgG antibody was assessed using enzyme linked immunosorbent assay. IL-1β and TNF-α polymorphisms were analyzed using a polymerase chain reaction with high resolution melting analysis. Associations between variables and ICC were assessed using conditional logistic regression.
RESULTS: Subjects with a high infection intensity had higher risk of ICC than those who had a low level (OR = 2.1; 95% CI: 1.2-3.9). Subjects with all genotypes of TNF-α (GG, GA, AA) and high infection intensity were significantly related to an increased risk of ICC (p < 0.05).
CONCLUSIONS: Polymorphisms of IL-1β and TNF-α are not a risk of ICC, but an individual with O. viverrini infection has an effect on all genotypes of the TNF-α gene that might promote ICC. Primary prevention of ICC in high-risk areas is based on efforts to reduce O. viverrini infection.

Entities:  

Keywords:  Cholangiocarcinoma; IL-1β; Opisthorchiasis; Polymorphism; TNF-α

Mesh:

Substances:

Year:  2018        PMID: 30139338      PMCID: PMC6108094          DOI: 10.1186/s12885-018-4751-5

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


Background

The incidence rate of intrahepatic cholangiocarcinoma (ICC) in the Northeast – the highest incidence in Thailand – from the last report, Cancer in Thailand, Vol. VII, 2007–2009, showed that it is the most common cancer in men (age-standardized incidence rate, ASR = 67.1 per 100,000) and the third most common cancer in women (ASR = 30.9). In Khon Kaen, located in Northeast Thailand, the incidence of ICC is ASR 57.4 in men, and 23.1 in women per 100,000 [1]. ICC is a multi-factor and inflammation-linked disease. Chronic inflammation and repeated infection with liver fluke, Opisthorchis viverrini (O. viverrini), induces ICC development [2-4]. Inflammatory cytokines increase inflammation and can cause diseases to progress rapidly. Interleukin-1β (IL-1β) and tumor necrosis factor-β (TNF-α) are inflammatory mediators that have been implicated in carcinogenesis due to its participation in chronic inflammatory diseases [5] including ICC [6]. The genesis of ICC is a multistep process, which required interaction between mutated biliary epithelial cells and environmental factors [7]. During ICC development, chronic inflammation of the bile duct caused by O. viverrini infection can induce the epithelial cells to produce a variety of cytokines, including IL-6, IL-8, TGF-β and TNF-α [8]. This can cause bile duct epithelial cell proliferation and impaired epithelial barrier function. As a result, somatic mutations occur in several tumor-related genes, leading to cholangiocarcinogenesis [6, 8–10]. Some studies reported the expression of TNF-α associated with ICC [6, 9], but genetic polymorphisms in TNF-α and ICC risk has not been explored so far and requires further study. IL-1β is a proinflammatory cytokine with multiple biological effects [11]. It has been implicated as an important factor for cancer progression. Genetic polymorphisms in IL-1β are associated with gastric cancer [12], hepatitis C virus [13-15] and hepatitis B virus [16] linked with hepatocellular carcinoma (HCC). However, there is no study of IL-1β genetic polymorphisms on ICC risk. The present study therefore aims to investigate risk factors for ICC and inflammation-linked cancer, and focus on opisthorchiasis and polymorphisms in proinflammatory cytokines (IL-1β and TNF-α) to assess whether these genes are involved in opisthorchiasis-related ICC risk.

Methods

Study design

This study was a part of a larger study known as the Khon Kaen Cohort Study (KKCS) that was previously conducted [17-20]. This was a suitable platform to test the hypothesis on a host-environment interaction influence risk of ICC. Briefly, positive subjects of ICC (ICD-10: 22.1) and a sample of non-affected controls that were enrolled participants in the KKCS were used in these experiments.

Study subjects

Among the 23,584 subjects admitted in the KKCS (male 32.6%: female 67.4%), 219 cohort participants (0.9%) that developed a primary malignancy of the intrahepatic bile ducts of the liver (C22.1) were identified (male 57.0%: female 43.0%). Since ICC is rarely diagnosed by liver biopsy and histopathology (6.9%), the criteria for inclusion as a case included diagnosis at least by ultrasound, with or without contrast radiology (9.6%) and tumor markers such as CA19–9 (83.5%). The vital status and date of death for potential cases were ascertained by linkage to the file of deaths in Thailand, in the database of the National Health Security Office (NHSO), together with the demographic database of Ministry of Interior. All ICC cases died within 2 years of diagnosis. Two non-cancer controls from the same cohort population were randomly selected for matching with each case based on sex and age at recruitment (±3 years).

Detection of O. viverrini-IgG antibody

Detection of O. viverrini-IgG antibody was assessed at the parasitological laboratory, Faculty of Medicine, Khon Kaen University, Thailand. The indirect enzyme linked with immunosorbent assay (ELISA) was used to analyze a serum of cases and their matched controls as reported before [21, 22]. The samples were analyzed as duplicates with the optical density (OD) at 620 nm under the ELISA reader. The mean OD was used as the cut-off value, OD ≤0.24 and OD > 0.24.

Analysis of IL-1β and TNF-α polymorphisms

Genomic DNA was extracted from buffy coat fractions of 170 cases (77.6%) of 219 eligible ICC cases and 355 (81.0%) of 438 matched controls using the standard protocols of Genomic DNA mini Kit with Proteinase K (Geneaid Biotech). The amplification of IL-1β C-511 T was achieved by using two primers, [F]:5′- AATTTCTCAGCCTCCTACTTC-3′ and [R]: 5′- GTTTGGTATCTGICCGTTTC-3′. The TNF-α G308A gene was amplified by using [F]: 5′- TAGGTTTTGAGGGGCATG -3′ and [R]: 5′- CTGGGICCCTGACTGATTT-3′ in a PCR reaction. Both genetic polymorphisms were performed in a LightCycler® 480 Real-Time PCR System with a final volume of 20 μl containing 10 μl of master mix, 4.4 μl of H2O, 3 mM of MgCl2, 0.3 μM of each primer and 200 ng of the DNA template. The data of high resolution melting analysis was analyzed using the LightCycler 480® Gene Scanning Software version 1.5 (Roche). Normalized melting curves and melting peaks of sequence variation were evaluated and compared with the wild-type sample. Different plots of melting peaks are illustrated in Fig. 1a for IL-1β C-511 T and Fig. 1b for TNF-α G-308A. Sequence variations were distinguished by the different shape of melting curves (Fig. 1c for IL-1β C-511T and Fig. 1d for TNF-α G-308A). To improve the genotyping quality and validation, 10% of random genotyping samples were confirmed by the PCR with restriction fragment length polymorphism techniques (PCR-RFLP).
Fig. 1

Polymorphisms in IL-1β C-511T and TNF-α G-308A were analyzed using the polymerase chain reaction with high resolution melting analysis (PCR-HRM)

Polymorphisms in IL-1β C-511T and TNF-α G-308A were analyzed using the polymerase chain reaction with high resolution melting analysis (PCR-HRM)

Statistical analysis

The link between O. viverrini infection intensity and proinflammatory cytokines polymorphisms (IL-1β and TNF-α) with the risk of developing ICC and odds ratios (ORs) were assessed and estimated at the 95% confidence and conditional logistic regression. The information about smoking, alcohol, and diet that was used for the adjusted ORs from the multivariate analysis in Table 2 has been previously reported [19, 20]. Possible modifications of the effects of O. viverrini infection intensity by proinflammatory cytokines polymorphisms (IL-1β and TNF-α) were also analyzed. Results that showed a p-value < 0.05 were statistically significant from the native control.
Table 2

Odds ratios for intrahepatic cholangiocarcinoma associated with O. viverrini infection intensity, and with IL-1β  and TNF-α polymorphisms

VariablesCasesControlsORa95% CIP-valueORb95% CIP-value
n% n %
O. viverrini-IgG antibody0.020.01
 OD ≤ 0.243218.810931.01.01.0
 OD > 0.2413881.224369.02.01.3–3.12.11.2–3.9
IL-1B C-511 T polymorphisms0.050.22
 CC4023.66919.51.01.0
 CT9958.218752.80.90.6–1.40.80.4–1.5
 TT3118.29827.70.50.3–0.90.40.2–0.8
TNF-A G-308A polymorphisms0.190.30
 GG10561.824468.81.01.0
 GA2917.15816.31.10.7–1.81.20.6–2.4
 AA3621.15314.91.61.0–2.61.70.9–3.3

aCrude odds ratios from matched case-control analysis

bAdjusted for smoking (no/yes), alcohol drinking (< 14/≥14 units of alcohol per month), dietary consumption: dish of raw freshwater fish, processed beef, papaya salad (non-consumer, < 1/month & monthly, weekly, daily), total fruits (< 52/≥52 average times per month), and total vegetables (< 35/≥35 average times per month)

Results

Out of 23,584 participants, 219 (0.9%) subjects developed ICC. This was comprised of 92 females and 127 males and with a median age of 57 years (Table 1). Additionally, there were two controls of the same sex and age for each case.
Table 1

General characteristics of intrahepatic cholangiocarcinoma cases and their matched controls

VariablesCasesControls
n = 219%n = 438%
Sex
 Female9242.018442.0
 Male12758.025458.0
Age at recruitment (years)
 30–3973.2133.0
 40–493415.57016.0
 50–599945.219945.4
 60–697936.115635.6
 Median (min: max)57 (31: 69)57 (30: 70)
Education level
 Illiterate2611.9153.4
 Primary school18584.539890.9
 Secondary school or higher83.7255.7
Marital status
 Single41.8112.5
 Married17379.036282.7
 Divorced146.4204.6
 Widowed2812.84510.3
Occupation
 Farmer19589.039991.1
 Government official52.3163.7
 Commercial156.9163.7
 General employee41.871.6
Household income per year (Baht)
 Less than 60,000 (Low)21397.341895.4
 60,001–119,999 (Medium)41.8102.3
  ≥ 120,000 (High)20.9102.3
 Median (min: max)10,000 (1200: 120,000)10,000 (1000: 360,000)
O. viverrini egg in stool
 Negative11562.223062.2
 Positive7037.814037.8
General characteristics of intrahepatic cholangiocarcinoma cases and their matched controls Table 2 shows the adjusted odds ratios (OR) and 95% CIs from the multivariate analyses, including the 10 factors identified as increasing risk in univariate analysis of ICC associated with O. viverrini infection intensity, IL-1β and TNF-α polymorphisms. Participants who had the O. viverrini-IgG antibody (OD > 0.24) possessed a higher risk for ICC than those who did not (OD ≤0.24) (adjusted OR 2.1; 95% CI: 1.2–3.9). In comparison, participants with TT variant of IL-1β C-511 T polymorphisms had a decreased risk of ICC (adjusted OR 0.4; 95% CI: 0.2–0.8). Results of interactions between O. viverrini infection intensity and IL-1β and TNF-α polymorphisms on the risk of ICC have been shown in Table 3. Participants with TNF-α in all genotypes (GG, GA, AA) who had high infection intensity (IgG antibody > 0.24) had an increased risk of ICC and were statistically significant (OR 2.1 for GG wild-type, OR 2.4 for GA heterozygote and OR 2.8 for AA variant). There were no interactions between O. viverrini infection intensity and the polymorphisms of IL-1β and TNF-α that influenced the risk of ICC.
Table 3

Interactions of O. viverrini infection intensity with IL-1β and TNF-α polymorphisms on the risk of intrahepatic cholangiocarcinoma in Thailand

PolymorphismsO. viverrini infection intensityCasesControlsORa95% CIP-valueP-valueb
n n
IL-1B C-511 TIgG antibody0.52
 CCOD ≤ 0.248271.0
 CTOD ≤ 0.2417560.90.4–2.50.90
 TTOD ≤ 0.247260.90.3–3.10.88
 CCOD > 0.2432422.50.9–6.60.06
 CTOD > 0.24821292.10.9–4.90.10
 TTOD > 0.2424721.10.4–2.80.89
TNF-A G-308AIgG antibody0.64
 GGOD ≤ 0.2418731.0
 GAOD ≤ 0.245200.90.3–2.80.87
 AAOD ≤ 0.248142.20.8–6.00.14
 GGOD > 0.24871692.11.2–3.70.01
 GAOD > 0.2424382.41.1–4.90.02
 AAOD > 0.2427372.81.4–5.80.01

aCrude odds ratios from matched case-control analysis

bP -value for interaction

Odds ratios for intrahepatic cholangiocarcinoma associated with O. viverrini infection intensity, and with IL-1β  and TNF-α polymorphisms aCrude odds ratios from matched case-control analysis bAdjusted for smoking (no/yes), alcohol drinking (< 14/≥14 units of alcohol per month), dietary consumption: dish of raw freshwater fish, processed beef, papaya salad (non-consumer, < 1/month & monthly, weekly, daily), total fruits (< 52/≥52 average times per month), and total vegetables (< 35/≥35 average times per month) Interactions of O. viverrini infection intensity with IL-1β and TNF-α polymorphisms on the risk of intrahepatic cholangiocarcinoma in Thailand aCrude odds ratios from matched case-control analysis bP -value for interaction

Discussion

In this work, our results successfully demonstrated the risk factors for ICC. For example, O. viverrini infection intensity detected by the IgG antibody was a risk factor for ICC and was comparable to previously reported studies in Northeast Thailand – Khon Kaen, [21] Nakhon Phanom [22] and Ubon Ratchathani [23]. Results obtained in this work showed the modified effects of O. viverrini infection with TNF-α codon 308 AA variant. Participants with only O. viverrini infection intensity had adjusted OR 2.1 (95% CI: 1.2–3.9), but participants who had both O. viverrini infection intensity together with AA variant of TNF-α had an increased OR of 2.8 (95% CI: 1.4–5.8). The genotype frequencies of IL-1β C-511 T and TNF-α G308A polymorphisms found in the controls were consistent with other studies in Thailand [16, 24]. Prevalence of C and T alleles of IL-1β codon 511 were 45.9% vs. 46.4% and 54.1% vs. 53.6%, respectively. In addition, the allele distribution of TNF-α G308A was also consistent as reported before [24]. Very limited information exists in Thailand that reported the associations of IL-1β C-511 T and TNF-α G-308A polymorphisms with the risk of various cancers, especially in chronic hepatitis B virus infection-linked HCC [16, 24]. Although, there was no study about the association of IL-1β C-511 T and TNF-α G308A polymorphisms on ICC risk until now, the study on cytokines expression related cancer has been reported which acts as a diagnostic marker for cancer. The detection of serum levels of cytokines (such as IL-6 or IL-10) may be linked to the process of carcinogenesis or poor prognosis [25-28]. In our current study of ICC, the role of TNF-α in inducing epithelial-mesenchymal transition (EMT) of ICC cells has been published recently [6]. Moreover, the profile of cytokine production in peripheral blood mononuclear cells collected from subjects with and without O. viverrini infection was evaluated. Eleven cytokine profiles (IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, TNF-α and LT-α), measured by flow cytometry, revealed that both pro-inflammatory and anti-inflammatory cytokines were increased in the O. viverrini-associated ICC compared to uninfected normal controls [29]. The basis of diagnosis of ICC was rarely done by histology (6.9%), and it is possible that other cases of fatal liver disease showing features of biliary obstruction, with a low serum alpha-fetoprotein, were possibly included in the case group. Despite this, the overall results support our hypothesis and are a pivotal factor in formulating experiments for future projects.

Conclusions

There was a known association between the polymorphisms of IL-1β and TNF-α. Polymorphisms of IL-1β C-511 T and TNF-α G-308A are not a risk of ICC but an individual with O. viverrini infection has effects on all genotypes of the TNF-α gene (GG, GA, AA) that might promote ICC. Primary prevention of ICC in high-risk areas is based on efforts to reduce O. viverrini infection.
  28 in total

1.  Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma.

Authors:  D M Parkin; P Srivatanakul; M Khlat; D Chenvidhya; P Chotiwan; S Insiripong; K A L'Abbé; C P Wild
Journal:  Int J Cancer       Date:  1991-05-30       Impact factor: 7.396

2.  MTHFR polymorphisms and Opisthorchis viverrini infection: a relationship with increased susceptibility to cholangiocarcinoma in Thailand.

Authors:  Nopparat Songserm; Supannee Promthet; Paiboon Sithithaworn; Chamsai Pientong; Tipaya Ekalaksananan; Peechanika Chopjitt; Donald Maxwell Parkin
Journal:  Asian Pac J Cancer Prev       Date:  2011

3.  Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma.

Authors:  Ewa Lech-Maranda; Jacques Bienvenu; Anne-Sophie Michallet; Roch Houot; Tadeusz Robak; Bertrand Coiffier; Gilles Salles
Journal:  Eur Cytokine Netw       Date:  2006-03       Impact factor: 2.737

4.  Risk factors for cholangiocarcinoma in the lower part of Northeast Thailand: a hospital-based case-control study.

Authors:  Mereerat Manwong; Nopparat Songserm; Supannee Promthet; Keitaro Matsuo
Journal:  Asian Pac J Cancer Prev       Date:  2013

5.  Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis.

Authors:  Katriina Heikkilä; Ross Harris; Gordon Lowe; Ann Rumley; John Yarnell; John Gallacher; Yoav Ben-Shlomo; Shah Ebrahim; Debbie A Lawlor
Journal:  Cancer Causes Control       Date:  2008-08-15       Impact factor: 2.506

6.  Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.

Authors:  P Kummee; P Tangkijvanich; Y Poovorawan; N Hirankarn
Journal:  J Viral Hepat       Date:  2007-12       Impact factor: 3.728

7.  Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma.

Authors:  Junji Komori; Hiroyuki Marusawa; Takafumi Machimoto; Yoko Endo; Kazuo Kinoshita; Tadayuki Kou; Hironori Haga; Iwao Ikai; Shinji Uemoto; Tsutomu Chiba
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

8.  Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini.

Authors:  Banchob Sripa; Bandit Thinkhamrop; Eimorn Mairiang; Thewarach Laha; Sasithorn Kaewkes; Paiboon Sithithaworn; Maria Victoria Periago; Vajarabhongsa Bhudhisawasdi; Ponlapat Yonglitthipagon; Jason Mulvenna; Paul J Brindley; Alex Loukas; Jeffrey M Bethony
Journal:  PLoS Negl Trop Dis       Date:  2012-05-22

Review 9.  Chronic inflammation and cytokines in the tumor microenvironment.

Authors:  Glauben Landskron; Marjorie De la Fuente; Peti Thuwajit; Chanitra Thuwajit; Marcela A Hermoso
Journal:  J Immunol Res       Date:  2014-05-13       Impact factor: 4.818

10.  Gene-environment interaction involved in cholangiocarcinoma in the Thai population: polymorphisms of DNA repair genes, smoking and use of alcohol.

Authors:  Nopparat Songserm; Supannee Promthet; Chamsai Pientong; Tipaya Ekalaksananan; Peechanika Chopjitt; Surapon Wiangnon
Journal:  BMJ Open       Date:  2014-10-21       Impact factor: 2.692

View more
  1 in total

Review 1.  The Functional Roles of Immune Cells in Primary Liver Cancer.

Authors:  Linh Pham; Konstantina Kyritsi; Tianhao Zhou; Ludovica Ceci; Leonardo Baiocchi; Lindsey Kennedy; Sanjukta Chakraborty; Shannon Glaser; Heather Francis; Gianfranco Alpini; Keisaku Sato
Journal:  Am J Pathol       Date:  2022-03-23       Impact factor: 5.770

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.